The CDC has recommended Pfizer's maternal RSVpreF vaccine (Abrysvo) to protect newborns from severe respiratory syncytial virus (RSV) illness, according to a news release. Approved by the FDA in August 2023, the vaccine has been shown to reduce the risk of RSV hospitalization by 57% for ...
"We have more tools than ever before and we have vaccines for all three major fall and winter respiratory viruses again. COVID, flu and for the first time we have an RSV vaccine for older adults and an RSV immunization for our infants," she said. The new drug, called Beyfortus, uses ...
The U.S. Centers for Disease Control and Prevention have recommended the first-ever vaccine designed to protect infants from respiratory syncytial virus. The CDC said the Pfizer vaccine should be taken during weeks 32 and 36 of pregnancy.Sept 23, 2023 ...
older, according to a recent CDC statement. The vaccines should be administered using shared clinical decision-making, meaning individuals can receive a single dose of the vaccine based on conversations with their health care provider about whether RSV vaccination is the best course of action for ...
In short, the new guidelines encourage all adults ages 75 and older and individuals who are between 60 and 74 with an elevated risk of getting severe RSV to get the RSV vaccine. For adults between 60 and 74 years, an elevated risk of severe RSV may be a result of a...
"This means these individuals may receive a single dose of the vaccine based on discussions with their healthcare provider about whether RSV vaccination is right for them," the CDC said in a statement. Among seniors, those in their early 60sare less likelyto face severe disease from RSV — ...
Pfizer has said its maternal vaccine couldpreventup to 16,000 hospitalizations and more than 300,000 visits to the doctor due to RSV if the shot becomes available in the U.S. this fall and winter. "This fall marks the start of the annual respiratory infection season in the Northern Hem...
The Centers for Disease Control and Prevention (CDC) updated its RSV vaccine guidance for seniors for this upcoming respiratory viral season, saying the new recommendations are meant to simplify decision-making for patients and clinicians. The new guidan
CDC Recommends RSV Immunization for Infants Trending Adverse Events After Immunization With Modified Vaccinia Ankara-Bavarian Nordic Vaccine for Mpox Research May 5, 2023 Third Dose of BNT162b2 Vaccine and SARS-CoV-2 Infection in Health Care Workers...
The ACIP did not hold a vote on whether to recommend RSV vaccination for patients aged 50 to 59 years despite the FDA’s recent decision to extend the approval of GSK’s vaccine for high-risk patients in that age group. References: ...